Submitted by Anonymous (not verified) on 25 October 2024 - 11:48
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 13, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jyseleca, filgotinib, Date of authorisation: 24/09/2020, Revision: 13, Status: Authorised